Floatz logo

Adrenomedullin

Cadasil

National Cerebral and Cardiovascular Center, Japanprotein_peptidePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Cadasil cohort.

Asset / SponsorPhaseRating
Hov-12020
Hovid Berhad
Phase 2B
Dabigatran
S. Andrea Hospital
Phase 2CCC
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION
Ever Neuro Pharma GmbH
Phase 2CCC
Cerebrolysin
Ever Neuro Pharma GmbH
Phase 2CCC
Fremanezumab
Mayo Clinic
Phase 2CCC
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Mayo Clinic
Phase 1/2CCC

Same molecule, other indications

Adrenomedullin is also rated in:

Neoplasm MetastasisDormant
B
Indicative ·
57 / 100
View asset →
Breast CancerDormant
CCC
Indicative ·
52 / 100
View asset →
central nervous system disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →